Aberrant cholesterol metabolism in colorectal cancer represents a targetable vulnerability
| dc.contributor.author | Xie, Jingwu | |
| dc.contributor.author | Nguyen, Chi Mai | |
| dc.contributor.author | Turk, Anita | |
| dc.contributor.author | Nan, Hongmei | |
| dc.contributor.author | Imperiale, Thomas F. | |
| dc.contributor.author | House, Michael | |
| dc.contributor.author | Huang, Kun | |
| dc.contributor.author | Su, Jing | |
| dc.contributor.department | Biostatistics, School of Public Health | |
| dc.date.accessioned | 2023-09-29T20:24:05Z | |
| dc.date.available | 2023-09-29T20:24:05Z | |
| dc.date.issued | 2023-07 | |
| dc.eprint.version | Final published version | |
| dc.identifier.citation | Xie, J., Nguyen, C. M., Turk, A., Nan, H., Imperiale, T. F., House, M., Huang, K., & Su, J. (2023). Aberrant cholesterol metabolism in colorectal cancer represents a targetable vulnerability. Genes & Diseases, 10(4), 1172–1174. https://doi.org/10.1016/j.gendis.2022.06.002 | |
| dc.identifier.other | 37397513 | |
| dc.identifier.uri | https://hdl.handle.net/1805/35905 | |
| dc.language.iso | en | |
| dc.publisher | Elsevier | |
| dc.relation.isversionof | 10.1016/j.gendis.2022.06.002 | |
| dc.relation.journal | Genes & Diseases | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.source | Publisher | |
| dc.subject | colorectal cancer | |
| dc.subject | cholesterol metabolism | |
| dc.title | Aberrant cholesterol metabolism in colorectal cancer represents a targetable vulnerability | |
| dc.type | Article |